Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints
01/04/2025 13:06
April 1 (Reuters) - Sernova Biotherapeutics Inc SVA.TO: SERNOVA BIOTHERAPEUTICS INC: STUDY IS ON TRACK TO MEET KEY CLINICAL TRIAL ENDPOINTS SERNOVA BIOTHERAPEUTICS INC: PROVIDED AN UPDATE ON ITS ONGOING CLINICAL TRIAL IN PATIENTS WITH T1D SERNOVA BIOTHERAPEUTICS INC: PREPARING TO ADVANCE TO COHORT C OF TRIAL IN H2 2025. Source text: ID:nGNX43mtTd Further company coverage: SVA.TO (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints